DE69532642D1 - Antivirale prodrugs - Google Patents
Antivirale prodrugsInfo
- Publication number
- DE69532642D1 DE69532642D1 DE69532642T DE69532642T DE69532642D1 DE 69532642 D1 DE69532642 D1 DE 69532642D1 DE 69532642 T DE69532642 T DE 69532642T DE 69532642 T DE69532642 T DE 69532642T DE 69532642 D1 DE69532642 D1 DE 69532642D1
- Authority
- DE
- Germany
- Prior art keywords
- prodrugs
- antiviral prodrugs
- antiviral
- phosphonoacids
- analogs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4062—Esters of acids containing the structure -C(=X)-P(=X)(XR)2 or NC-P(=X)(XR)2, (X = O, S, Se)
- C07F9/4065—Esters of acids containing the structure -C(=X)-P(=X)(XR)2, (X = O, S, Se)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/40—Esters thereof
- C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4075—Esters with hydroxyalkyl compounds
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US340161 | 1994-11-15 | ||
US08/340,161 US5696277A (en) | 1994-11-15 | 1994-11-15 | Antiviral prodrugs |
PCT/US1995/014940 WO1996015132A1 (en) | 1994-11-15 | 1995-11-15 | Improved antiviral prodrugs |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69532642D1 true DE69532642D1 (de) | 2004-04-08 |
DE69532642T2 DE69532642T2 (de) | 2005-06-30 |
Family
ID=23332146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69532642T Expired - Lifetime DE69532642T2 (de) | 1994-11-15 | 1995-11-15 | Antivirale prodrugs |
Country Status (11)
Country | Link |
---|---|
US (2) | US5696277A (de) |
EP (1) | EP0792275B1 (de) |
JP (1) | JPH10508858A (de) |
AT (1) | ATE260926T1 (de) |
AU (1) | AU700651B2 (de) |
CA (1) | CA2205136C (de) |
DE (1) | DE69532642T2 (de) |
DK (1) | DK0792275T3 (de) |
ES (1) | ES2217287T3 (de) |
PT (1) | PT792275E (de) |
WO (1) | WO1996015132A1 (de) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6458772B1 (en) | 1909-10-07 | 2002-10-01 | Medivir Ab | Prodrugs |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5696277A (en) * | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
EP1655033A1 (de) | 1995-06-07 | 2006-05-10 | Emory University | Nucleoside mit anti-hepatitis B virus Wirksamkeit |
TW343975B (en) * | 1995-12-15 | 1998-11-01 | Boehringer Mannheim Gmbh | New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents |
SE9603726D0 (sv) * | 1996-10-11 | 1996-10-11 | Astra Ab | Novel compounds |
SE9604582D0 (sv) * | 1996-12-13 | 1996-12-13 | Astra Ab | Novel compounds |
US6686462B2 (en) | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
US20030229040A1 (en) * | 1997-03-21 | 2003-12-11 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
US6126965A (en) * | 1997-03-21 | 2000-10-03 | Georgetown University School Of Medicine | Liposomes containing oligonucleotides |
US7262173B2 (en) * | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
US6559129B1 (en) * | 1997-03-21 | 2003-05-06 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
ES2276515T3 (es) | 1998-02-25 | 2007-06-16 | Emory University | 2'-fluoronucleosidos. |
WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
US6444837B1 (en) * | 1998-07-13 | 2002-09-03 | University Of Southern California | Synthesis and antiviral activity of a series of pyrophosphate analogs |
CN100387237C (zh) | 1998-08-10 | 2008-05-14 | 艾丹尼克斯(开曼)有限公司 | 用于治疗乙型肝炎的β-L-2'-脱氧-核苷 |
US6444652B1 (en) | 1998-08-10 | 2002-09-03 | Novirio Pharmaceuticals Limited | β-L-2'-deoxy-nucleosides for the treatment of hepatitis B |
DE69923338T2 (de) | 1998-11-02 | 2006-04-06 | Gilead Sciences, Inc., Foster City | Kombinationstherapie zur behandlung von hepatitis b infektionen |
WO2001047511A2 (en) * | 1999-12-29 | 2001-07-05 | The Regents Of The University Of California | Treatment of drug-resistant human immunodeficiency virus infection |
CN1268345C (zh) | 2000-03-29 | 2006-08-09 | 乔治敦大学 | 治疗丁型肝炎病毒感染的核苷化合物 |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
CN101099745A (zh) | 2000-05-26 | 2008-01-09 | 艾登尼科斯(开曼)有限公司 | 处理黄病毒和瘟病毒的方法和组合物 |
US6787526B1 (en) | 2000-05-26 | 2004-09-07 | Idenix Pharmaceuticals, Inc. | Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides |
US6875751B2 (en) | 2000-06-15 | 2005-04-05 | Idenix Pharmaceuticals, Inc. | 3′-prodrugs of 2′-deoxy-β-L-nucleosides |
KR20090089922A (ko) | 2000-10-18 | 2009-08-24 | 파마셋 인코포레이티드 | 바이러스 감염 및 비정상적인 세포 증식의 치료를 위한 변형된 뉴클레오시드 |
WO2002087500A2 (en) * | 2001-04-27 | 2002-11-07 | Newbiotics, Inc. | Viral enzyme activated prototoxophores and use of same to treat viral infections |
US7608600B2 (en) * | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
RS113904A (en) * | 2002-06-28 | 2007-02-05 | Idenix (Cayman) Limited | 2'-c-methyl-3'-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
PL374831A1 (en) | 2002-06-28 | 2005-10-31 | Idenix (Cayman) Limited | Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections |
CN101172993A (zh) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷 |
TWI244393B (en) | 2002-08-06 | 2005-12-01 | Idenix Pharmaceuticals Inc | Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
US7186700B2 (en) | 2002-09-13 | 2007-03-06 | Idenix Pharmaceuticals, Inc. | β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies |
US20070207973A1 (en) * | 2002-09-24 | 2007-09-06 | Koronis Pharmaceuticals, Incorporated | 1,3,5-Triazines for Treatment of Viral Diseases |
JP2006507255A (ja) * | 2002-09-24 | 2006-03-02 | コローニス ファーマシューティカルズ インコーポレイテッド | ウイルス疾患の治療のための1,3,5−トリアジン |
HUE033832T2 (en) | 2002-11-15 | 2018-01-29 | Idenix Pharmaceuticals Llc | 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation |
US7598373B2 (en) | 2002-12-12 | 2009-10-06 | Idenix Pharmaceuticals, Inc. | Process for the production of 2-C-methyl-D-ribonolactone |
BR0316868A (pt) * | 2002-12-23 | 2005-10-25 | Idenix Cayman Ltd | Processo para a produção de pró-medicamentos de nucleosìdeo-3' |
KR100883703B1 (ko) | 2003-05-30 | 2009-02-12 | 파마셋 인코포레이티드 | 변형 불소화 뉴클레오시드 유사체 |
JP2007501185A (ja) | 2003-07-25 | 2007-01-25 | イデニクス(ケイマン)リミテツド | C型肝炎を含むフラビウイルス関連疾患を治療するためのプリンヌクレオシド類似体 |
WO2005045310A2 (en) * | 2003-10-27 | 2005-05-19 | Wimberly Randal L | Dual reflector system |
WO2005090370A1 (en) | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
MXPA06011219A (es) | 2004-03-29 | 2007-05-08 | Univ South Florida | Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados. |
EP1912643A2 (de) * | 2004-06-23 | 2008-04-23 | Idenix (Cayman) Limited | 5-aza-7-deazapurinderivate zur behandlung von infektionen mit flaviviridae |
SI3109244T1 (sl) | 2004-09-14 | 2019-06-28 | Gilead Pharmasset Llc | Priprava 2'fluoro-2'-alkil-substituiranih ali drugih neobvezno substituiranih ribofuranozil pirimidinov in purinov in njihovih derivatov |
TW200628161A (en) * | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
WO2006110655A2 (en) | 2005-04-08 | 2006-10-19 | Chimerix, Inc. | Compounds, compositions and methods for the treatment of poxvirus infections |
US20070003608A1 (en) * | 2005-04-08 | 2007-01-04 | Almond Merrick R | Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
CN102924549A (zh) | 2005-09-26 | 2013-02-13 | 吉利德制药有限责任公司 | 作为抗病毒剂的修饰的4'-核苷 |
CA2634749C (en) | 2005-12-23 | 2014-08-19 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
US8895531B2 (en) | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
US20080039428A1 (en) * | 2006-06-29 | 2008-02-14 | Panacos Pharmaceuticals, Inc. | Antiretroviral combination therapy |
US7950880B2 (en) * | 2006-10-18 | 2011-05-31 | Kennametal Inc. | Spiral flute tap |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
CN101977610B (zh) | 2008-01-25 | 2012-05-16 | 奇默里克斯公司 | 治疗病毒感染的方法 |
EP3042660A3 (de) | 2008-04-15 | 2016-10-26 | RFS Pharma, LLC. | Nukleosidderivate zur behandlung von caliciviridae-infektionen, einschliesslich norovirus-infektionen |
EP2671888A1 (de) | 2008-12-23 | 2013-12-11 | Gilead Pharmasset LLC | 3',5'-zyklische Nucleosidphosphatanaloga |
NZ617066A (en) | 2008-12-23 | 2015-02-27 | Gilead Pharmasset Llc | Nucleoside analogs |
CA2748057C (en) | 2008-12-23 | 2018-07-03 | Pharmasset, Inc. | Nucleoside phosphoramidates |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
US8614200B2 (en) | 2009-07-21 | 2013-12-24 | Chimerix, Inc. | Compounds, compositions and methods for treating ocular conditions |
PT2534150T (pt) | 2010-02-12 | 2017-05-02 | Chimerix Inc | Métodos para tratar uma infecção viral |
WO2011139709A2 (en) | 2010-04-26 | 2011-11-10 | Chimerix, Inc. | Methods of treating retroviral infections and related dosage regimes |
AU2011336632B2 (en) | 2010-11-30 | 2015-09-03 | Gilead Pharmasset Llc | Compounds |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
CA3131037A1 (en) | 2011-11-30 | 2013-06-06 | Emory University | Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
BR112015023705A8 (pt) | 2013-03-15 | 2020-03-17 | Univ California | compostos, composições farmacêuticas, usos de um composto, e método para síntese do composto da fórmula (ia) |
EP4005560A1 (de) | 2013-08-27 | 2022-06-01 | Gilead Pharmasset LLC | Kombinationsformulierung von zwei antiviralen verbindungen |
KR20230145550A (ko) | 2014-09-15 | 2023-10-17 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 뉴클레오타이드 유사체 |
EP3875462A1 (de) | 2015-09-15 | 2021-09-08 | The Regents of The University of California | Nukleotidanaloga |
WO2018023054A1 (en) * | 2016-07-28 | 2018-02-01 | Kansas State University Research Foundation | Protease transition state inhibitor prodrugs |
CA3105038A1 (en) * | 2018-06-26 | 2020-01-02 | Tsrl, Inc. | Metabolically stable prodrugs |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7607496L (sv) * | 1976-07-01 | 1978-01-02 | Astra Laekemedel Ab | Sett for bekempning av virusinfektioner |
CA1144937A (en) * | 1977-12-22 | 1983-04-19 | Dke J.E. Helgstrand | Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections |
US5072032A (en) * | 1989-06-21 | 1991-12-10 | Mckenna Charles E | Preparation and use of thiophosphonates and thio-analogues of phosphonoformic acid |
US5411947A (en) * | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
WO1994013321A1 (en) * | 1992-12-09 | 1994-06-23 | Indiana University Foundation | Suppression of myeloid cells |
US5696277A (en) * | 1994-11-15 | 1997-12-09 | Karl Y. Hostetler | Antiviral prodrugs |
-
1994
- 1994-11-15 US US08/340,161 patent/US5696277A/en not_active Expired - Lifetime
-
1995
- 1995-11-15 CA CA002205136A patent/CA2205136C/en not_active Expired - Fee Related
- 1995-11-15 EP EP95940014A patent/EP0792275B1/de not_active Expired - Lifetime
- 1995-11-15 AU AU41635/96A patent/AU700651B2/en not_active Ceased
- 1995-11-15 ES ES95940014T patent/ES2217287T3/es not_active Expired - Lifetime
- 1995-11-15 DE DE69532642T patent/DE69532642T2/de not_active Expired - Lifetime
- 1995-11-15 JP JP8516340A patent/JPH10508858A/ja active Pending
- 1995-11-15 PT PT95940014T patent/PT792275E/pt unknown
- 1995-11-15 DK DK95940014T patent/DK0792275T3/da active
- 1995-11-15 AT AT95940014T patent/ATE260926T1/de not_active IP Right Cessation
- 1995-11-15 WO PCT/US1995/014940 patent/WO1996015132A1/en active IP Right Grant
-
1997
- 1997-12-08 US US08/986,881 patent/US6002029A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0792275T3 (da) | 2004-07-05 |
CA2205136A1 (en) | 1996-05-23 |
ES2217287T3 (es) | 2004-11-01 |
EP0792275B1 (de) | 2004-03-03 |
EP0792275A1 (de) | 1997-09-03 |
US6002029A (en) | 1999-12-14 |
PT792275E (pt) | 2004-09-30 |
ATE260926T1 (de) | 2004-03-15 |
EP0792275A4 (de) | 1998-02-25 |
AU700651B2 (en) | 1999-01-14 |
CA2205136C (en) | 2008-01-22 |
AU4163596A (en) | 1996-06-06 |
DE69532642T2 (de) | 2005-06-30 |
WO1996015132A1 (en) | 1996-05-23 |
JPH10508858A (ja) | 1998-09-02 |
US5696277A (en) | 1997-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69532642D1 (de) | Antivirale prodrugs | |
DE69129479T2 (de) | Verteiltes Rechnersystem | |
ATE199906T1 (de) | Phosphonat-nukleotid ester-derivate | |
DE69128017D1 (de) | Verteiltes rechnersystem | |
DE69305413D1 (de) | Pulverisierungsvorrichtung | |
KR930702893A (ko) | 상보시스템을 저해하거나 또는 면역활성을 억제하는 성분물 | |
FR2591483B1 (fr) | Compositions pharmaceutiques antivirales et antitumorales. | |
DE69327153T2 (de) | Anti-hiv-medikament | |
DE69121446D1 (de) | Zerstäubungssystem | |
DE69328050T2 (de) | Rücklaufsperre | |
FI964619A0 (fi) | Epilepsialääkkeiden iholle annostelu | |
NO840104L (no) | Oksalkylerte polyamidoaminer, samt anvendelse av dem | |
DE69311862T2 (de) | Kontinuierliche Dispergiervorrichtung | |
DE69302723T2 (de) | Mehrreihige Wechselrichteranordnung | |
IT1229295B (it) | Differenziale bloccabile | |
FI925423A0 (fi) | Anordning foer att anordna permanenta magneter till en maenniskans kropp | |
DE9314628U1 (de) | Höschenwindel | |
KR940006900U (ko) | 유아용 멜빵 | |
AU1871592A (en) | Novel reference influenza viruses and antiviral drug susceptibility methods | |
KR970000135U (ko) | 아기용 멜빵 | |
PT8490T (pt) | Cadeira de bebe multiusos | |
SE9203298D0 (sv) | Laekemedel med antidopamineffekt | |
KR960031081U (ko) | 안전거리 지시형 백밀러 | |
MX9203510A (es) | Fenilpiperidilaminas y drogas que las contienen. | |
BR7302524U (pt) | Cadeira suspense para crianças |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8332 | No legal effect for de | ||
8370 | Indication related to discontinuation of the patent is to be deleted | ||
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: CHIMERIX, INC., DEL MAR, CALIF., US |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: CHIMERIX, INC., LA JOLLA, CALIF., US |